BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17553653)

  • 1. Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma.
    Takatori H; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Sasaki K; Tamotsu K; Owaki T; Ishigami S; Aikou T
    Eur J Surg Oncol; 2008 Apr; 34(4):397-402. PubMed ID: 17553653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus.
    Nozoe T; Ezaki T; Kabashima A; Baba H; Maehara Y
    Am J Surg; 2005 Jan; 189(1):110-5. PubMed ID: 15701502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis: clinicopathological and prognostic significance of cyclooxygenase-2 expression on oesophageal squamous cell carcinoma.
    Li L; Zhao J; Wu Z; Wang G; Chen G
    Aliment Pharmacol Ther; 2009 Sep; 30(6):589-96. PubMed ID: 19549265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
    Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
    Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
    Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
    Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
    J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
    Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
    Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic expression of type VII collagen is related to prognosis in patients with esophageal squamous cell carcinoma.
    Baba Y; Iyama K; Honda S; Ishikawa S; Miyanari N; Baba H
    Oncology; 2006; 71(3-4):221-8. PubMed ID: 17652943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
    Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
    Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
    Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
    Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma.
    Byeon JS; Jung HY; Lee YJ; Lee D; Lee GH; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI; Kim JS
    J Gastroenterol Hepatol; 2004 Jun; 19(6):648-54. PubMed ID: 15151619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma.
    Makino T; Yamasaki M; Takemasa I; Takeno A; Nakamura Y; Miyata H; Takiguchi S; Fujiwara Y; Matsuura N; Mori M; Doki Y
    Ann Surg Oncol; 2009 Jul; 16(7):2058-64. PubMed ID: 19408050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
    Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
    Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.
    Liu P; Chen W; Zhu H; Liu B; Song S; Shen W; Wang F; Tucker S; Zhong B; Wang D
    Jpn J Clin Oncol; 2009 Oct; 39(10):644-50. PubMed ID: 19648590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
    Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
    Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
    Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
    Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
    Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
    Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma.
    Faried A; Nakajima M; Sohda M; Miyazaki T; Kato H; Kuwano H
    Eur J Surg Oncol; 2005 May; 31(4):410-4. PubMed ID: 15837049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus.
    Yamada A; Sasaki H; Aoyagi K; Sano M; Fujii S; Daiko H; Nishimura M; Yoshida T; Chiba T; Ochiai A
    Oncol Rep; 2008 Nov; 20(5):1021-7. PubMed ID: 18949396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Yokomakura N; Kita Y; Matsumoto M; Uchikado Y; Setoyama T; Owaki T; Ishigami S; Aikou T
    Clin Cancer Res; 2006 Jun; 12(12):3740-5. PubMed ID: 16778101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.